SLC5A2 and pulmonary edema: Patient with reduced ejection fraction < 45% or overt pulmonary edema were treated with diuretics & goal directed medical therapy to reduce mortality and rehospitalization using angiotensin receptor-neprilysin inhibitor (ARNI) or angiotensin blockers with maximum tolerated dose, in addition to beta blockers, aldosterone antagonists and sodium-glucose cotransporter-2 inhibitors.